Dipyridamole (Zydus Pharmaceuticals (USA) Inc.)


Welcome to the PulseAid listing for the Dipyridamole drug offered from Zydus Pharmaceuticals (USA) Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Zydus Pharmaceuticals (USA) Inc.
NON-PROPRIETARY NAME: Dipyridamole
SUBSTANCE NAME: DIPYRIDAMOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-05-22
END MARKETING DATE: 0000-00-00


Dipyridamole HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDipyridamole from Zydus Pharmaceuticals (USA) Inc.
LABELER NAME: Zydus Pharmaceuticals (USA) Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2008-05-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68382-187_2854052e-996b-4bdf-9f4d-f6286df82b71
PRODUCT NDC: 68382-187
APPLICATION NUMBER: ANDA040874

Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationDipyridamole
Avera McKennan HospitalDipyridamole
Boehringer Ingelheim Pharmaceuticals, Inc.Persantine
Cadila Healthcare LimitedDipyridamole
Cardinal HealthDIPYRIDAMOLE
Carilion Materials ManagementDipyridamole
General Injectables & Vaccines, IncDipyridamole
Lannett Company, Inc.Dipyridamole
Major PharmaceuticalsDIPYRIDAMOLE
NCS HealthCare of KY, Inc dba Vangard LabsDipyridamole
Rising Pharmaceuticals, Inc.DIPYRIDAMOLE
Roxane Laboratories, Inc.Dipyridamole
Teva Pharmaceuticals USA, Inc.Dipyridamole
West-ward Pharmaceutical Corp.Dipyridamole
Zydus Pharmaceuticals (USA) Inc.Dipyridamole